28.56MMarket Cap-856P/E (TTM)
3.5500High3.1926Low20.42KVolume3.2900Open3.2600Pre Close69.27KTurnover0.25%Turnover RatioLossP/E (Static)8.42MShares9.238852wk High-2.59P/B28.09MFloat Cap3.050052wk Low--Dividend TTM8.29MShs Float1304.4000Historical High--Div YieldTTM10.96%Amplitude3.0500Historical Low3.3910Avg Price1Lot Size
Dare Bioscience Stock Forum
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
Benzinga
Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with or without concomitant decreased desire
There are currently no FDA-approved ...
As an Investor Catalyst Hub spoke, Daré gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spok...
No comment yet